Evidence map›Paper›PMID 38827612›Full record

ArticleFrontiers in public health2024

Smart homes: pioneering age-friendly environments in China for enhanced health and quality of life.

Ingy Shafei, Jyoti Khadka, Madhan Balasubramanian

Abstract read
In one paragraph

Article in Frontiers in public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ingy ShafeiCollege of Business, Government and Law, Flinders University, Adelaide, SA, Australia.
Jyoti KhadkaCollege of Nursing and Health Sciences, Flinders University, Adelaide, SA, Australia.
Madhan BalasubramanianCollege of Business, Government and Law, Flinders University, Adelaide, SA, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Traditionally, China has been more reliant on a model of care that ensures older adults are cared for by family members. Whilst promoting the idea of older adults ageing in their own homes is essential, the provision of in-home care must shift from primarily relying on family caregivers to a model that places greater emphasis on gerontechnologies and enhanced healthcare service delivery. In this perspective article we argue for the adoption of a 'smart home' model in aged care in China. The smart home model argues for innovative technologies to older adult care, such as virtual support groups, video-conferencing, and electronic health records; assistive technologies that can safely maintain independence and assist with daily living such as sensors, wearables, telehealth, smart home technologies as well as interactive robotic technologies for mobility and cognitive support such as humanoid robots, rehabilitation robots, service/companion robots. The adoption and implementation of gerontechnologies have been slow, with only a handful of solutions demonstrating proven effectiveness in supporting home care. The utilisation of such digital technologies to support and enable older adults in China to age-in-place can bring a significant contribution to healthy ageing. Nonetheless, it's crucial to focus on co-creating with end-users, incorporating their values and preferences, and enhancing training to boost the adoption of these gerontechnologies. Through a smart home model of care, China can age-in-place more effectively, leading to significant contributions to healthy ageing.

Indexed as

Home Care ServicesQuality of LifeAgedCaregiversChinaHumansIndependent LivingSelf-Help DevicesTelemedicineageingChinagerontechnologieshome caremodels of careolder adultssmart home

Identifiers

PMID38827612
PMCPMC11141166

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.